Your browser doesn't support javascript.
loading
Tripeptide gut hormone infusion does not alter food preferences or sweet taste function in volunteers with obesity and prediabetes/diabetes but promotes restraint eating: A secondary analysis of a randomized single-blind placebo-controlled study.
Behary, Preeshila; Alessimii, Haya; Miras, Alexander D; Tharakan, George; Alexiadou, Kleopatra; Aldhwayan, Madhawi M; Purkayastha, Sanjay; Moorthy, Krishna; Ahmed, Ahmed R; Bloom, Stephen R; Tan, Tricia M.
Affiliation
  • Behary P; Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
  • Alessimii H; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
  • Miras AD; Clinical Nutrition Department, College of Applied Medical Sciences, Umm Al Qura University, Mecca, Saudi Arabia.
  • Tharakan G; Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
  • Alexiadou K; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
  • Aldhwayan MM; School of Medicine, Ulster University, Londonderry, UK.
  • Purkayastha S; Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
  • Moorthy K; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
  • Ahmed AR; Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
  • Bloom SR; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
  • Tan TM; Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Diabetes Obes Metab ; 25(6): 1731-1739, 2023 06.
Article in En | MEDLINE | ID: mdl-36811311
ABSTRACT

AIMS:

To investigate whether the elevation in postprandial concentrations of the gut hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM) and peptide YY (PYY) accounts for the beneficial changes in food preferences, sweet taste function and eating behaviour after Roux-en-Y gastric bypass (RYGB). MATERIALS AND

METHODS:

This was a secondary analysis of a randomized single-blind study in which we infused GLP-1, OXM, PYY (GOP) or 0.9% saline subcutaneously for 4 weeks in 24 subjects with obesity and prediabetes/diabetes, to replicate their peak postprandial concentrations, as measured at 1 month in a matched RYGB cohort (ClinicalTrials.gov NCT01945840). A 4-day food diary and validated eating behaviour questionnaires were completed. Sweet taste detection was measured using the method of constant stimuli. Correct sucrose identification (corrected hit rates) was recorded, and sweet taste detection thresholds (EC50s half maximum effective concencration values) were derived from concentration curves. The intensity and consummatory reward value of sweet taste were assessed using the generalized Labelled Magnitude Scale.

RESULTS:

Mean daily energy intake was reduced by 27% with GOP but no significant changes in food preferences were observed, whereas a reduction in fat and increase in protein intake were seen post-RYGB. There was no change in corrected hit rates or detection thresholds for sucrose detection following GOP infusion. Additionally, GOP did not alter the intensity or consummatory reward value of sweet taste. A significant reduction in restraint eating, comparable to the RYGB group was observed with GOP.

CONCLUSION:

The elevation in plasma GOP concentrations after RYGB is unlikely to mediate changes in food preferences and sweet taste function after surgery but may promote restraint eating.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Gastric Bypass / Gastrointestinal Hormones Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prediabetic State / Gastric Bypass / Gastrointestinal Hormones Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: United kingdom